Genmab to Hold 2024 R&D Update and ASH Data Review Meeting

GlobeNewswireDec 11 08:20 ET

City of Hope Reports Novel Immunotherapy in Clinical Trial Shows Promise for Patients With Relapsed or Difficult to Treat Chronic Lymphocytic Leukemia (CLL)

BusinesswireDec 10 08:00 ET

EU Specialty Pharma to See Product Launches But Limited Clinical Data Next Year -- Market Talk

WSJDec 10 02:05 ET

AbbVie And Genmab A/S Present Two Data Analyses From Clinical Trials Show Epcoritamab Induces Durable Complete Reponses As Monotherapy And Combination Treatment In Patients With Diffuse Large B-Cell Lymphoma; Results From Arm 1 Of The EPCORE NHL-2...

BenzingaDec 9 12:03 ET

Genmab's Chronic Lymphocytic Leukemia Antibody Shows High Response Rates

MT NewswiresDec 8 23:56 ET

Genmab Announces New Results From Phase 1b/2 EPCORE NHL-2 Trial

TipRanksDec 8 07:05 ET